Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 14:17:39 UTC |
---|
Update Date | 2022-03-07 02:49:13 UTC |
---|
HMDB ID | HMDB0002163 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Trihydroxycoprostanoic acid |
---|
Description | Trihydroxycoprostanoic acid is excreted in the urine of patients with Zellweger syndrome (PMID 7347441 ), a genetic disorder. The oxidation trihydroxycoprostanic acid is deficient in liver homogenates from patients with peroxisomal diseases (PMID 2576087 ). Trihydroxycoprostanoic acid is found to be associated with adrenoleukodystrophy (ALD), which is also an inborn error of metabolism. |
---|
Structure | [H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)C[C@@]2(C[C@H](O)CC[C@]12C)C(O)=O InChI=1S/C28H48O5/c1-16(2)7-6-8-17(3)19-9-10-20-24-21(13-23(31)27(19,20)5)26(4)12-11-18(29)14-28(26,25(32)33)15-22(24)30/h16-24,29-31H,6-15H2,1-5H3,(H,32,33)/t17-,18-,19-,20+,21+,22-,23+,24+,26-,27-,28+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Trihydroxycoprostanoate | Generator | 3 alpha,7 alpha,12 alpha-Trihydroxycoprostanic acid | MeSH | 3,7,12-Trihydroxycoprostanic acid | MeSH | 3 alpha,7 alpha,12 alpha-Trihydroxy-5 beta-cholestanoic acid | MeSH | (3a,5b,7a,12a)-3,7,12-Trihydroxy-cholestane-5-carboxylate | HMDB | (3a,5b,7a,12a)-3,7,12-Trihydroxy-cholestane-5-carboxylic acid | HMDB | (3alpha,5beta,7alpha,12alpha)-3,7,12-Trihydroxycholestane-5-carboxylate | HMDB | (3alpha,5beta,7alpha,12alpha)-3,7,12-Trihydroxycholestane-5-carboxylic acid | HMDB | 3,7,12-Trihydroxycoprostanate | HMDB | 3alpha,7alpha,12alpha-Trihydroxycoprostanate | HMDB | 3alpha,7alpha,12alpha-Trihydroxycoprostanic acid | HMDB | 5-Thca | HMDB, MeSH | Tryhydroxycoprostanate | HMDB | Tryhydroxycoprostanic acid | HMDB | (1S,2R,5R,7R,9R,10R,11S,14R,15R,16S)-5,9,16-Trihydroxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-7-carboxylate | Generator, HMDB |
|
---|
Chemical Formula | C28H48O5 |
---|
Average Molecular Weight | 464.6777 |
---|
Monoisotopic Molecular Weight | 464.350174646 |
---|
IUPAC Name | (1S,2R,5R,7R,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-7-carboxylic acid |
---|
Traditional Name | (1S,2R,5R,7R,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-7-carboxylic acid |
---|
CAS Registry Number | 863-39-8 |
---|
SMILES | [H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)C[C@@]2(C[C@H](O)CC[C@]12C)C(O)=O |
---|
InChI Identifier | InChI=1S/C28H48O5/c1-16(2)7-6-8-17(3)19-9-10-20-24-21(13-23(31)27(19,20)5)26(4)12-11-18(29)14-28(26,25(32)33)15-22(24)30/h16-24,29-31H,6-15H2,1-5H3,(H,32,33)/t17-,18-,19-,20+,21+,22-,23+,24+,26-,27-,28+/m1/s1 |
---|
InChI Key | JIFNDZCDNLFAKC-YAODFNMUSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Cholestane steroids |
---|
Direct Parent | Cholesterols and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Cholesterol
- Cholesterol-skeleton
- Steroid acid
- 3-hydroxysteroid
- 12-hydroxysteroid
- Hydroxysteroid
- 3-alpha-hydroxysteroid
- 7-hydroxysteroid
- Cyclic alcohol
- Secondary alcohol
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Polyol
- Carboxylic acid derivative
- Organooxygen compound
- Alcohol
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Trihydroxycoprostanoic acid,1TMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O)C[C@H]3O | 3566.3 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TMS,isomer #2 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C | 3531.3 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TMS,isomer #3 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O | 3598.1 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TMS,isomer #4 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O | 3503.2 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O | 3485.6 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TMS,isomer #2 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O | 3431.1 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TMS,isomer #3 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C | 3491.4 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TMS,isomer #4 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C | 3459.1 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TMS,isomer #5 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O[Si](C)(C)C | 3408.1 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TMS,isomer #6 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O | 3430.1 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O | 3400.2 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TMS,isomer #2 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C | 3444.4 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TMS,isomer #3 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O[Si](C)(C)C | 3423.7 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TMS,isomer #4 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O[Si](C)(C)C | 3374.9 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,4TMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C)C[C@H]3O[Si](C)(C)C | 3401.5 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TBDMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O)C[C@H]3O | 3780.7 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TBDMS,isomer #2 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C(C)(C)C | 3750.6 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TBDMS,isomer #3 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O | 3840.7 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,1TBDMS,isomer #4 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O | 3771.4 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TBDMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O | 3949.2 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TBDMS,isomer #2 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O | 3912.2 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TBDMS,isomer #3 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C(C)(C)C | 3933.0 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TBDMS,isomer #4 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C(C)(C)C | 3920.5 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TBDMS,isomer #5 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O[Si](C)(C)C(C)(C)C | 3884.5 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,2TBDMS,isomer #6 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O | 3941.6 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TBDMS,isomer #1 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O | 4118.0 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TBDMS,isomer #2 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O)C[C@H]3O[Si](C)(C)C(C)(C)C | 4123.2 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TBDMS,isomer #3 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O[Si](C)(C)C(C)(C)C)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O[Si](C)(C)C(C)(C)C | 4108.8 | Semi standard non polar | 33892256 | Trihydroxycoprostanoic acid,3TBDMS,isomer #4 | CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]1(C(=O)O[Si](C)(C)C(C)(C)C)C[C@H]3O[Si](C)(C)C(C)(C)C | 4076.0 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Trihydroxycoprostanoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-006w-1151900000-9964b763512a2672587e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Trihydroxycoprostanoic acid GC-MS (3 TMS) - 70eV, Positive | splash10-014i-3214059000-4094305c0a69ba80bb14 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Trihydroxycoprostanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 10V, Positive-QTOF | splash10-002b-0000900000-b0a4411cb2684a1a2972 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 20V, Positive-QTOF | splash10-0fba-1101900000-990e05e4698fd587ab83 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 40V, Positive-QTOF | splash10-0avi-8404900000-1b74f95b874b3c97fd32 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 10V, Negative-QTOF | splash10-03dj-0000900000-bad6122da3518cc7d5b6 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 20V, Negative-QTOF | splash10-0wmj-0000900000-e2d7732c54b6600adc8a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 40V, Negative-QTOF | splash10-0v00-1002900000-8baa3514da0d45921e79 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 10V, Negative-QTOF | splash10-03di-0000900000-915fa80269f79ccefd03 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 20V, Negative-QTOF | splash10-03di-0000900000-f34f75240f81eb3f52f1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 40V, Negative-QTOF | splash10-03di-0003900000-546ed85bdaefe541670e | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 10V, Positive-QTOF | splash10-014j-0000900000-3f74f7ede1344fce4d83 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 20V, Positive-QTOF | splash10-0zfr-5103900000-7ac26fb2207619da057a | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trihydroxycoprostanoic acid 40V, Positive-QTOF | splash10-052f-9322000000-2321f8e3f4c0e7f6b080 | 2021-09-25 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | - Extracellular
- Membrane
- Peroxisome
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0 uM | Newborn (0-30 days old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 8.8 uM | Infant (0-1 year old) | Male | Pseudo Zellweger->D-bifunctional protein deficiency | | details | Blood | Detected and Quantified | 11.4 +/- 5.2 uM | Adult (>18 years old) | Both | Zellweger syndrome | | details | Blood | Detected and Quantified | 10.9 +/- 14.6 uM | Newborn (0-30 days old) | Both | Adrenoleukodystrophy (ALD) | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Peroxisomal biogenesis defect |
---|
- Watkins PA, Chen WW, Harris CJ, Hoefler G, Hoefler S, Blake DC Jr, Balfe A, Kelley RI, Moser AB, Beard ME, et al.: Peroxisomal bifunctional enzyme deficiency. J Clin Invest. 1989 Mar;83(3):771-7. [PubMed:2921319 ]
| Adrenoleukodystrophy |
---|
- Watkins PA, Chen WW, Harris CJ, Hoefler G, Hoefler S, Blake DC Jr, Balfe A, Kelley RI, Moser AB, Beard ME, et al.: Peroxisomal bifunctional enzyme deficiency. J Clin Invest. 1989 Mar;83(3):771-7. [PubMed:2921319 ]
| D-Bifunctional protein deficiency |
---|
- Watkins PA, Chen WW, Harris CJ, Hoefler G, Hoefler S, Blake DC Jr, Balfe A, Kelley RI, Moser AB, Beard ME, et al.: Peroxisomal bifunctional enzyme deficiency. J Clin Invest. 1989 Mar;83(3):771-7. [PubMed:2921319 ]
|
|
---|
Associated OMIM IDs | - 214100 (Peroxisomal biogenesis defect)
- 300100 (Adrenoleukodystrophy)
- 261515 (D-Bifunctional protein deficiency)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022877 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 108961 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 6519 |
---|
PubChem Compound | 122166 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 89753 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000381 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Casteels M, Van Roermund CW, Schepers L, Govaert L, Eyssen HJ, Mannaerts GP, Wanders RJ: Deficient oxidation of trihydroxycoprostanic acid in liver homogenates from patients with peroxisomal diseases. J Inherit Metab Dis. 1989;12(4):415-22. [PubMed:2576087 ]
- Wanders RJ, Schutgens RB, Heymans HS: Deficient cholesterol side chain oxidation in patients without peroxisomes (Zellweger syndrome): evidence for the involvement of peroxisomes in bile acid synthesis in man. Clin Chim Acta. 1987 Feb 15;162(3):295-301. [PubMed:3568406 ]
- Muller-Hocker J, Bise K, Endres W, Hubner G: [Morphology and diagnosis of Zellweger syndrome. A contribution to combined cytochemical-finestructural identification of peroxisomes in autopsy material and frozen liver tissue with case report]. Virchows Arch A Pathol Anat Histol. 1981;393(1):103-14. [PubMed:7347441 ]
|
---|